These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32247358)

  • 1. Increasing Resistance to Third-Generation Cephalosporins in Spontaneous Bacterial Peritonitis.
    Tripathi N; Koirala N; Kato H
    Mayo Clin Proc; 2020 Apr; 95(4):828-829. PubMed ID: 32247358
    [No Abstract]   [Full Text] [Related]  

  • 2. In reply - Increasing Resistance to Third-Generation Cephalosporins in Spontaneous Bacterial Peritonitis.
    Simonetto DA
    Mayo Clin Proc; 2020 Apr; 95(4):829-830. PubMed ID: 32247359
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and Predictors of Third-Generation Cephalosporin Resistance in the Empirical Treatment of Spontaneous Bacterial Peritonitis.
    Sunjaya DB; Lennon RJ; Shah VH; Kamath PS; Simonetto DA
    Mayo Clin Proc; 2019 Aug; 94(8):1499-1508. PubMed ID: 31303428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.
    Fiore M; Gentile I; Maraolo AE; Leone S; Simeon V; Chiodini P; Pace MC; Gustot T; Taccone FS
    Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):329-336. PubMed ID: 29303883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
    Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
    J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
    Heywood A; Bargman JM
    Adv Perit Dial; 2010; 26():34-6. PubMed ID: 21348376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
    Lutz P; Nischalke HD; Krämer B; Goeser F; Kaczmarek DJ; Schlabe S; Parcina M; Nattermann J; Hoerauf A; Strassburg CP; Spengler U
    Eur J Clin Invest; 2017 Jan; 47(1):44-52. PubMed ID: 27861767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage.
    Novovic S; Semb S; Olsen H; Moser C; Knudsen JD; Homann C
    Scand J Gastroenterol; 2012 Feb; 47(2):212-6. PubMed ID: 22191479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
    Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalosporin resistance in Malawi.
    Haigh K; Dube Q; Kasambara W; Feasey NA; Lester R
    Lancet Infect Dis; 2020 Mar; 20(3):285-286. PubMed ID: 32112760
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity.
    Eyal A; Greif F; Shalit I; Lelcuk S
    Isr J Med Sci; 1996 Dec; 32(12):1317-9. PubMed ID: 9007180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic usage for initial empirical treatment of infections in hospitalized patients in West Germany.
    Knothe H
    Infection; 1991; 19(3):127-30. PubMed ID: 1889863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
    Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G
    J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spontaneous bacterial peritonitis].
    Strauss E; Caly WR
    Rev Soc Bras Med Trop; 2003; 36(6):711-7. PubMed ID: 15049112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-generation cephalosporins in the treatment of rare infections.
    Finch RG
    Am J Med; 1990 Apr; 88(4A):25S-31S. PubMed ID: 2183606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
    Goyanes MJ; Cercenado E; Insa R; Morente A; Alcalá L; Bouza E
    Rev Esp Quimioter; 2007 Jun; 20(2):216-21. PubMed ID: 17893759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections.
    Dupeyron C; Campillo SB; Mangeney N; Richardet JP; Leluan G
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):427-32. PubMed ID: 11583211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spontaneous bacterial peritonitis: impact of microbiological changes].
    Almeida PR; Camargo NS; Arenz M; Tovo CV; Galperim B; Behar P
    Arq Gastroenterol; 2007; 44(1):68-72. PubMed ID: 17639187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneous and secondary bacterial peritonitis in cirrhotic patients with ascites].
    Bruns T; Stallmach A
    Zentralbl Chir; 2014 Apr; 139(2):160-7. PubMed ID: 22144140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.